Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9M Buy
290,400
+45,800
+19% +$5.29M 0.06% 316
2025
Q4
$25.7M Buy
244,600
+100,200
+69% +$9.41M 0.04% 412
2025
Q3
$12.1M Sell
144,400
-102,500
-42% -$8.44M 0.02% 704
2025
Q2
$19.5M Buy
246,900
+1,700
+0.7% +$135K 0.04% 516
2025
Q1
$22M Buy
245,200
+40,300
+20% +$3.76M 0.06% 404
2024
Q4
$20.4M Buy
204,900
+71,600
+54% +$7.38M 0.05% 422
2024
Q3
$15.1M Buy
133,300
+57,100
+75% +$6.78M 0.04% 559
2024
Q2
$9.43M Buy
76,200
+12,300
+19% +$1.58M 0.02% 728
2024
Q1
$8.43M Sell
63,900
-1,400
-2% -$173K 0.02% 775
2023
Q4
$7.12M Buy
+65,300
New +$6.78M 0.02% 809
2023
Q3
Sell
-3,000
Closed -$323K 1661
2023
Q2
$346K Buy
+3,000
New +$341K ﹤0.01% 1688
2023
Q1
Hold
0
2045

Other funds holding MRK

Man Group's MRK Position: Q1 2026 in Review

Man Group reduced its Merck (MRK) stake by 57% in Q1 2026, selling an estimated $121M and leaving 793,167 shares worth $95.4M. The position accounts for 0.17% of the portfolio, ranked #129.

Man Group first reported a position in MRK in Q1 2018 and has held it in 30 quarters since. The position peaked at $260M in Q1 2021. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Man Group held 793,167 shares of Merck worth $95.4M as of Q1 2026.
  • Man Group sold 1,050,361 Merck shares in Q1 2026, an estimated $121M.
  • Merck made up 0.17% of Man Group's portfolio in Q1 2026, its #129 holding.
  • Man Group first reported a position in Merck in Q1 2018 and has held it in 30 quarters since.
  • Man Group's Merck position peaked at $260M in Q1 2021.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.